Table 1.

The numbers of somatic variants analyzed in this study and the ESE‐disrupting variants identified

TCGA project	The number of samples	The number of total variants	The number of ESE‐disrupting variants	The percentage of ESE‐disrupting variants
ACC	79	538	0	0
PCPG	179	336	2	0.60
CHOL	36	308	2	0.65
BLCA	408	5084	27	0.53
GBM	154	4600	21	0.46
LGG	516	2228	5	0.22
BRCA	1092	9079	34	0.37
CESC	305	3742	17	0.45
COAD	431	11 507	38	0.33
READ	151	2555	12	0.47
ESCA	182	2638	11	0.42
UVM	80	158	0	0
HNSC	520	4068	11	0.27
KICH	66	258	1	0.39
KIRC	531	1227	5	0.41
KIRP	290	1202	2	0.17
LIHC	371	38 398	94	0.24
LUAD	516	7204	27	0.37
LUSC	500	9198	40	0.43
DLBC	48	773	3	0.39
OV	304	1822	9	0.49
PAAD	177	2696	8	0.30
MESO	87	175	0	0
PRAD	497	1451	7	0.48
SKCM	104	2229	16	0.72
SARC	258	1854	11	0.59
STAD	379	7299	38	0.52
TGCT	147	344	0	0
THYM	120	1048	2	0.19
THCA	505	494	0	0
UCEC	545	31 875	201	0.63
UCS	57	406	2	0.49
Total	9635	156 794	646	0.41